• 2,7-Dichlorodihydrofluorescein Diacetate in Oxidative Stress

  2026-06-10

  2,7-Dichlorodihydrofluorescein diacetate (DCFH-DA) is the gold-standard probe for sensitive, live-cell detection of intracellular ROS, empowering researchers to dissect oxidative stress in models of inflammation, mitochondrial dysfunction, and cytotoxicity. Leveraging recent advances in ulcerative colitis research, this guide delivers optimized workflows and practical troubleshooting tips for maximizing assay accuracy using APExBIO’s trusted reagent.

• THZ1: Expanding the Role of Covalent CDK7 Inhibitors in T-AL

  2026-06-09

  Explore how THZ1, a potent covalent CDK7 inhibitor, is reshaping transcription regulation studies in T-cell acute lymphoblastic leukemia (T-ALL). This article uncovers unique mechanistic insights, practical assay guidance, and the latest cross-disciplinary findings.

• LY364947: Applied Protocols for TGF-β Type I Receptor Kinase

  2026-06-09

  LY364947 empowers researchers to dissect TGF-β signaling and suppress epithelial-mesenchymal transition (EMT) with robust, reproducible results. This guide delivers actionable protocol enhancements, advanced use-cases, and troubleshooting strategies for maximizing LY364947's impact in EMT, fibrosis, and retinal degeneration assays.

• BML-277: Precision Chk2 Inhibitor for DNA Damage Response Re

  2026-06-08

  BML-277 enables rigorous, selective inhibition of Chk2 in DNA damage response and radioprotection studies, with exceptional potency and clear workflow advantages. Its role in dissecting the Chk2-cGAS-TRIM41 axis sets a new standard for functional genomic and cancer research.

• Nilotinib (AMN-107): Precision Tyrosine Kinase Inhibition in

  2026-06-08

  Nilotinib (AMN-107) is a selective, orally available tyrosine kinase inhibitor widely used in chronic myeloid leukemia (CML) and kinase-driven cancer research. Its nanomolar potency against BCR-ABL and KIT mutants, along with proven immunomodulatory effects in colorectal cancer models, make it a benchmark tool in translational oncology studies.

• KN-62 and CaMKII: Precision Tools for Synaptic Memory Resear

  2026-06-07

  Explore how KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine, enables unprecedented insight into calcium/calmodulin-dependent kinase II (CaMKII) signaling and synaptic memory maintenance. This article uniquely integrates molecular mechanisms with cutting-edge findings in social memory, offering researchers new directions for experimental design.

• Antipyrine in CNS Permeability Modeling: Advanced Research I

  2026-06-06

  Explore the scientific utility of Antipyrine in advanced blood-brain barrier modeling and CNS pharmacokinetic research. This article offers a novel, mechanistic analysis of 1,5-dimethyl-2-phenylpyrazol-3-one, highlighting its value for high-throughput permeability prediction and experimental accuracy.

• KN-62 Enables Precision Inhibition of Calcium Signaling Path

  2026-06-05

  KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine offers unmatched selectivity for dissecting CaMKII-dependent signaling, with robust, reproducible effects on secretion, metabolism, and cell cycle arrest. This guide translates cutting-edge reference findings and literature-backed workflows into practical, optimized protocols for advanced calcium signaling research.

• 6-Thioguanine Inhibits EV71 Replication via BIRC3-Mediated A

  2026-06-05

  This study demonstrates that 6-thioguanine, a known antineoplastic agent, significantly inhibits Enterovirus 71 (EV71) replication by suppressing BIRC3-driven autophagy in human cells. These findings highlight a novel antiviral mechanism, with implications for repurposing established drugs against viral diseases lacking targeted therapies.

• Optimizing hiPSC Platelet Differentiation with Small Molecul

  2026-06-04

  This study presents a systematically optimized protocol for differentiating functional platelets from human induced pluripotent stem cells (hiPSCs), leveraging higher embryoid body input, serum-free medium with human platelet lysate, and small-molecule modulators. The resulting protocol significantly improves platelet yield, shortens differentiation time, and reduces production costs, offering a scalable solution for regenerative medicine and cell therapy.

• 10074-G5: Benchmark c-Myc Inhibitor for Cancer Research

  2026-06-04

  10074-G5 is a validated small-molecule c-Myc inhibitor that disrupts c-Myc/Max dimerization, induces apoptosis, and achieves tumor regression in preclinical models. It shows measurable efficacy in both in vitro and in vivo cancer research applications, with stable solubility and well-characterized pharmacological parameters.

• ERK Pathway Links IFNγ Signaling to Melanoma Cell Death

  2026-06-03

  Champhekar et al. reveal that ERK activation is a critical mediator of interferon gamma (IFNγ)-induced apoptosis in melanoma, independent of common oncogenic mutations. This discovery refines our understanding of immune signaling in tumor suppression and suggests new avenues for targeting melanoma resistance.

• Plk1 Regulation of p31comet in Mitotic Checkpoint Complex Di

  2026-06-03

  This study elucidates how Polo-like kinase 1 (Plk1) modulates the function of p31comet, a key player in mitotic checkpoint complex (MCC) disassembly. By revealing the phosphorylation-dependent inhibition of p31comet by Plk1, the findings advance understanding of mitotic checkpoint regulation and highlight implications for cell cycle research and targeted cancer studies.

• Super-Enhancer Hijacking of LINC01977 Drives LUAD Progressio

  2026-06-02

  Zhang et al. (2022) reveal that super-enhancer hijacking activates LINC01977, which promotes early-stage lung adenocarcinoma progression via the canonical TGF-β/SMAD3 pathway. This mechanistic insight highlights a new epigenetic vulnerability and suggests potential avenues for transcriptional coactivator inhibition in lung cancer biology research.

• VTA-PBN Dopaminergic Projections Accelerate Propofol Emergen

  2026-06-02

  This study demonstrates that dopaminergic neurons projecting from the ventral tegmental area (VTA) to the parabrachial nucleus (PBN) play a critical role in facilitating emergence from propofol anesthesia in rats. Using targeted chemogenetic and optogenetic approaches, the research provides new insight into neuronal circuits governing anesthetic recovery.

7968 records 10/532 page Previous Next First page 上5页 678910 下5页 Last page